Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 13Neoplasm Metastasis 2Recurrence 1Hormone Receptor Positive Breast Carcinoma 1HER2-positive Metastatic Breast Cancer 1Genetic Diseases, Inborn 1Endometrial Neoplasms 1Carcinoma, Ductal, Breast 1Advanced HER2+Breast Cancer 1Advanced Breast Cancer 1

Interventions

Paclitaxel 2Letrozole 2Carboplatin 2Vorinostat 1Trastuzumab 1Taxes 1Radiotherapy 1Gonadotropin-Releasing Hormone 1Fulvestrant 1Doxorubicin 1Docetaxel 1Cyclophosphamide 1Cisplatin 1Anastrozole 1Alpelisib 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Ductal, Breast × Alpelisib × Clear all
NCT01791478 2024-07-23

BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer

Vanderbilt-Ingram Cancer Center

Phase 1 Active not recruiting
46 enrolled
Breast

Breast Neoplasms, Carcinoma, Ductal, Breast

Data powered by HemOnc (CC BY 4.0) Colophon âš¡